Impact of end-stage renal disease on clinical and angiographic outcomes after coronary stenting

American Journal of Cardiology

Volumn 86, Issue 5, 2000, Pages 485-489

  Azar, Rabih R ^a   Prpic, Ross ^b   Ho, Kalon K L ^a   Kiernan, Francis J ^c   Shubrooks Jr , Samuel J ^a   Baim, Donald S ^a   Popma, Jeffrey J ^b   Kuntz, Richard E ^b   Cohen, David J ^a  

^a BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c HARTFORD HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ANGIOCARDIOGRAPHY; ARTICLE; CARDIOVASCULAR DISEASE; CHRONIC KIDNEY DISEASE; CLINICAL ARTICLE; CLINICAL PROTOCOL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY DISEASE; CORONARY STENT; FEMALE; HUMAN; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RESTENOSIS; RISK ASSESSMENT; SAPHENOUS VEIN GRAFT; TRANSLUMINAL CORONARY ANGIOPLASTY; TREATMENT OUTCOME;

AGED; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; CORONARY ANGIOGRAPHY; CORONARY DISEASE; DISEASE-FREE SURVIVAL; FEMALE; FOLLOW-UP STUDIES; HUMANS; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; RECURRENCE; STENTS; TREATMENT OUTCOME;

EID: 0034284114     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9149(00)00998-X     Document Type: Article

References (30)

1. Lindner A., Charra B., Sherrard D.J., Scribner B.H. Accelerated atherosclerosis in prolonged maintenance hemodialysis. N Engl J Med. 290:1974;697-700.
2. Huysmans K., Lins R.L., Daelemans R., Zachee P., De Broe M.E. Hypertension and accelerated atherosclerosis in end-stage renal disease. J Nephrol. 11:1998;185-195.
3. Renal Data System. USRDS 1997 Annual Data Report. Bethesda, MD: National Institute of Diabetes and Digestive and Kidney Diseases (NIH publication no. 97-3176), April 1997:91-101.
4. Ko W., Kreiger K.H., Isom O.W. Cardiopulmonary bypass procedures in dialysis patients. Ann Thorac Surg. 55:1993;677-684.
5. Owen C.H., Cummings R.G., Sell T.L., Schwab S.J., Jones R.H., Glower D.D. Coronary artery bypass grafting in patients with dialysis dependent renal failure. Ann Thorac Surg. 58:1994;1729-1733.
6. Kahn J.K., Rutherford B.D., McConahay D.R., Johnson W.L., Giorgi L.V., Hartzler G.O. Short-and long-term outcome of percutaneous transluminal coronary angioplasty in chronic dialysis patients. Am Heart J. 119:1990;484-489.
7. Ahmed W.H., Shubrooks S.J., Gibson C.M., Baim D.S., Bittl J.A. Complications and long-term outcome after percutaneous coronary angioplasty in chronic hemodialysis patients. Am Heart J. 128:1994;252-255.
8. Reusser L.M., Osborn L.A., White H.J., Sexson R., Crawford M.H. Increased morbidity after coronary angioplasty in patients on chronic hemodialysis. Am J Cardiol. 73:1994;965-967.
9. Rinehart A.L., Herzog C.A., Collins A.J., Flack J.M., Ma J.Z., Opsahl J.A. A comparison of coronary angioplasty and coronary artery bypass grafting outcomes in chronic dialysis patients. Am J Kidney Dis. 25:1995;281-290.
10. Koyanagi T., Nishida H., Kitamura M., Endo M., Koyanagi H., Kawaguchi M., Magosaki N., Sumiyoshi T., Hosoda S. Comparison of clinical outcomes of coronary artery bypass grafting and percutaneous transluminal coronary angioplasty in renal dialysis patients. Ann Thorac Surg. 61:1996;1793-1796.
11. Marso S.P., Gimple L.W., Philbrick J.T., DiMarco J.P. Effectiveness of percutaneous coronary interventions to prevent recurrent coronary events in patients on chronic hemodialysis. Am J Cardiol. 82:1998;378-380.
12. A comparison of balloon-expandable stent implantation with balloon angioplasty in patients with coronary artery disease. N Engl J Med. 331:1994;489-495.
13. A randomized comparison of coronary-stent placement and balloon angioplasty in the treatment of coronary artery disease. N Engl J Med. 331:1994;496-501.
14. Leon M.B., Baim D.S., Popma J., Gordon P.C., Cutlip D.E., Ho K.K., Giambartolomei A., Diver D.J., Lasorda D.M., Williams D.O., Pocock S.J., Kuntz R.E. A clinical trial comparing three antithrombotic-drug regimes after coronary artery stenting. N Engl J Med. 339:1998;1665-1671.
15. Cutlip D.E., Leon M.B., Ho K.K.L., Gordon P.C., Giambartolomei A., Diver D.J., Lasorda D.M., Williams D.O., Fitzpatrick M.M., Desjardin A., Popma J.J., Kuntz R.E., Baim D.S. Acute and nine-month clinical outcomes after "suboptimal" coronary stenting. Results from the Stent Antithrombotic Regimen Study (STARS) registry. J Am Coll Cardiol. 34:1999;698-706.
16. Kuntz R.E., Gibson C.M., Nobuyoshi M., Baim D.S. Generalized model of restenosis after conventional balloon angioplasty, stenting and directional atherectomy. J Am Coll Cardiol. 21:1993;15-25.
17. Kastrati A., Schomig A., Elezi S., Schuhlen H., Dirschinger J., Hadamitzky M., Wehinger A., Hausleiter J., Walter H., Neumann F.J. Predictive factors of restenosis after coronary stent placement. J Am Coll Cardiol. 30:1997;1428-1436.
18. Bauters C., Hubert E., Prat A., Bougrimi K., van Belle E., McFadden E.P., Amoyel P., Lablanche J.M., Bertrand M. Predictors of restenosis after coronary stent implantation. J Am Coll Cardiol. 31:1998;1291-1298.
19. Kimura T., Nosaka H., Yokoi H., Iwabuchi M. Serial angiographic follow-up after Palmaz-Schatz stent implantation comparison with conventional balloon angioplasty . J Am Coll Cardiol. 21:1993;1557-1563.
20. Gibson C.M., Kuntz R.E., Nobuyoshi M., Rosner B., Baim D.S. Lesion-to-lesion independence of restenosis after treatment by conventional angioplasty, stenting or directional atherectomy-validation of lesion-based restenosis analysis. Circulation. 87:1993;1123-1129.
21. Savage M.P., Douglas J.S., Fischman D.L., Pepine C.J., King S.B., Werner J.A., Bailey S.R., Overlie P.A., Fenton S.H., Brinker J.A., Leon M.B., Goldberg S. Stent placement compared with balloon angioplasty for obstructed coronary bypass grafts. N Engl J Med. 337:1997;740-747.
22. Serruys P.W., van Hout B., Bonnier H., Legrand V., Garcia E., Macaya C., Sousa E., van der Giessen W., Colombo A., Seabra-Gomes R., et al. Randomised comparison of implantation of heparin-coated stents with balloon angioplasty in selected patients with coronary artery disease (Benestent II). Lancet. 352:1998;673-681.
23. Blacher J., Guerin A.P., Pannier B., Marchais S.J., Safar M.E., London G.M. Impact of aortic stiffness on survival in end-stage renal disease. Circulation. 99:1999;2434-2439.
24. Blacher J., London G.M., Safar M.E., Mourad J.J. Influence of age and end-stage renal disease on the stiffness of carotid wall material in hypertension. J Hypertension. 17:1999;237-244.
25. Schwartz R.S., Murphy J.G., Edwards W.D., Camrud A.R., Vliestra R.E., Holmes D.R. Restenosis after balloon angioplasty. A practical proliferative model in porcine coronary arteries. Circulation. 82:1990;2190-2200.
26. Hoffmann R., Mintz G.S., Mehran R., Kent K.M., Pichard A.D., Satler L.F., Leon M.B. Tissue proliferation within and surrounding Palmaz-Schatz stents is dependent on the aggressiveness of stent implantation technique. Am J Cardiol. 83:1999;1170-1174.
27. Sabo R.S., Bartoli F., Apitz-Castro R. In vivo platelet hyperactivity, another risk factor for patients under continuous ambulatory peritoneal dialysis. Nephron. 49:1988;228-230.
28. Viener A., Aviram M., Better O.S., Brook J.G. Enhanced in vitro platelet aggregation in hemodialysis patients. Nephron. 43:1986;139-143.
29. Notohamiprodjo M., Andrassy K., Bommer J., Ritz E. Dialysis membranes and the coagulation system. Blood Purif. 4:1986;130-141.
30. Excerpts from United States Renal Data System. Annual Data Report. Am J Kidney Dis 1998;32(suppl.):1:S9-S141.